Bz-L-Phe-NH2

Bz-L-Phe-NH2 is an L-phenylalanine primary amide bearing a benzyl (Bz) carbonyl protecting group on the amino acid nitrogen, giving a chiral amino acid derivative with an aromatic side chain and a terminal amide functionality. The structure contains a stereogenic center at the α-carbon, a benzamide-type N-protection motif, and an aniline-like primary amide (-CONH2) that participates in hydrogen bonding and can be selectively derivatized. The benzoyl-protected amide framework supports controlled peptide coupling after appropriate activation or deprotection, while the phenyl side chain enables hydrophobic interactions and aromatic ring chemistry in downstream scaffold design. The compound's combination of protected amine, free amide NH2, and stereochemical integrity makes it a practical intermediate for peptide building block preparation and for constructing amide-linked analogs in synthetic organic chemistry.

1. Peptide Synthesis

Bz-L-Phe-NH2 is used in peptide synthesis workflows where an L-phenylalanine unit must be introduced as an amide-containing building block. The benzoyl-protected amino nitrogen and the stereodefined α-amino acid backbone allow compatibility with standard peptide coupling strategies after converting the carboxamide functionality into the appropriate coupling handle or after orthogonal deprotection. The terminal primary amide can be retained for generating peptide amide termini or transformed into activated derivatives for sequential chain extension. Aromatic side-chain phenylalanine chemistry supports formation of hydrophobic peptide segments and can influence folding-relevant conformations in peptide analogs. Bz-L-Phe-NH2 therefore functions as a stereochemically defined intermediate for constructing amide-linked peptides and peptide fragments used in research-grade synthesis.

2. Amino Acid Derivatization

Bz-L-Phe-NH2 is applied in amino acid derivatization and fine chemical synthesis to access substituted phenylalanine amide derivatives with controlled functional group placement. The benzoyl (Bz) protection on the nitrogen provides a stable handle during side-chain and terminal amide transformations, while the primary amide NH2 enables formation of ureas, carboxamides, or other nitrogen-containing derivatives through standard electrophile-driven modifications. The chiral α-center preserves stereochemical information for downstream stereoselective synthesis and for preparing enantiopure libraries. The phenyl side chain can be further functionalized through electrophilic aromatic substitution or cross-coupling after appropriate activation of the aromatic ring, enabling structure-activity relationship (SAR) studies of aromatic substitution patterns. Bz-L-Phe-NH2 thus serves as a chemically tractable precursor for generating a range of protected-amide amino acid analogs used in synthetic methodology development.

3. Bioconjugation Chemistry

Bz-L-Phe-NH2 is suitable for chemical biology and bioconjugation strategies where an amino acid-derived amide motif is needed for controlled attachment chemistries. The terminal primary amide can be converted into reactive intermediates or conjugation-ready derivatives that participate in amide bond formation with biomolecule carboxylates or in coupling schemes that preserve stereochemistry at the α-carbon. The benzoyl-protected nitrogen helps minimize undesired cross-reactivity during conjugation steps, supporting selectivity when other nucleophilic sites are present on the target biomolecule. The phenylalanine aromatic side chain contributes to hydrophobic contacts and can affect local microenvironment around the conjugation site in labeled constructs. Bz-L-Phe-NH2 can therefore be incorporated into amino acid-based linkers, peptide mimetics, and bioconjugation intermediates used for biomolecule labeling and analytical reagent preparation.

4. SAR Studies And Peptidomimetics

Bz-L-Phe-NH2 is employed in SAR studies and peptidomimetic design where stereochemically defined phenylalanine amide fragments are assembled into constrained or modified scaffolds. The combination of an L-configuration at the α-carbon and an aromatic side chain supports reproducible incorporation into analog series that probe hydrophobic and steric contributions to binding or recognition. The benzoyl-protected nitrogen and the terminal amide NH2 enable systematic variation of terminal functionality, including conversion to alternative amide/urea motifs that can modulate hydrogen-bonding patterns. The resulting phenylalanine-derived fragments can be used to build peptide-like structures with altered backbone composition while maintaining key side-chain geometry. Bz-L-Phe-NH2 thus acts as a stereodefined intermediate for constructing amide-rich peptidomimetics used in medicinal chemistry research and molecular design.

5. Pharmaceutical Intermediate Preparation

Bz-L-Phe-NH2 is used as a controlled intermediate in pharmaceutical intermediate preparation and specialty chemical production, particularly for routes requiring enantiopure phenylalanine-derived amide units. The benzoyl-protected amide framework provides a protected nitrogen that can be carried through multi-step synthetic sequences with reduced risk of side reactions, while the primary amide NH2 serves as a functional handle for downstream conversion to other nitrogen-containing groups. The stereochemical integrity of the L-configuration supports manufacturing of enantiopure building blocks used in the synthesis of peptide-like active pharmaceutical ingredient (API) fragments and related intermediates. The aromatic phenylalanine side chain can be leveraged for constructing hydrophobic domains typical of many bioactive scaffolds, including amide-linked linkers and constrained analogs. Bz-L-Phe-NH2 therefore fits industrially relevant synthesis planning where protected amino acid derivatives and amide-functional intermediates must be assembled reproducibly.

1. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

2. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

4. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

5. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis